Desirée Hao

Outcome and prognostic factors in soft tissue sarcoma in the adult

J. LeVay, Brian O’Sullivan, Charles Catton et al. · International Journal of Radiation Oncology*Biology*Physics · 1993 · 204 citations

Prognostic Factors, Surgical Oncology, Soft Tissue Sarcoma +6

Clinical Cancer Advances 2005: Major Research Advances in Cancer Treatment, Prevention, and Screening—A Report From the American Society of Clinical Oncology

Roy S. Herbst, Dean F. Bajorin, Harry Bleiberg et al. · Journal of Clinical Oncology · 2005 · 120 citations · Full text

Tumor Biology, Targeted Cancer Therapies, Medicine +13

Sequential treatment with afatinib and osimertinib in patients with <i>EGFR</i> mutation-positive non-small-cell lung cancer: an observational study

Maximilian J. Hochmair, Alessandro Morabito, Desirée Hao et al. · Future Oncology · 2018 · 96 citations · Full text

Pan Canadian Rash Trial: A Randomized Phase III Trial Evaluating the Impact of a Prophylactic Skin Treatment Regimen on Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor–Induced Skin Toxicities in Patients With Metastatic Lung Cancer

Barbara Melosky, Helén Anderson, Ronald L. Burkes et al. · Journal of Clinical Oncology · 2015 · 91 citations

Phase I/II Trial of Custirsen (OGX-011), an Inhibitor of Clusterin, in Combination with a Gemcitabine and Platinum Regimen in Patients with Previously Untreated Advanced Non-small Cell Lung Cancer

Janessa Laskin, Garth Nicholas, Christopher Lee et al. · Journal of Thoracic Oncology · 2011 · 86 citations

Oncology, Medicine, Bronchial Neoplasm +6